GB9403250D0 - Therapeutic use of myelin-associated glycoprotein (mag) - Google Patents
Therapeutic use of myelin-associated glycoprotein (mag)Info
- Publication number
- GB9403250D0 GB9403250D0 GB9403250A GB9403250A GB9403250D0 GB 9403250 D0 GB9403250 D0 GB 9403250D0 GB 9403250 A GB9403250 A GB 9403250A GB 9403250 A GB9403250 A GB 9403250A GB 9403250 D0 GB9403250 D0 GB 9403250D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- myelin
- mag
- therapeutic use
- associated glycoprotein
- glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9403250A GB9403250D0 (en) | 1994-02-21 | 1994-02-21 | Therapeutic use of myelin-associated glycoprotein (mag) |
AU17035/95A AU1703595A (en) | 1994-02-21 | 1995-02-17 | Therapeutic use of myelin-associated glycoprotein (mag) |
PCT/CA1995/000089 WO1995022344A1 (en) | 1994-02-21 | 1995-02-17 | Therapeutic use of myelin-associated glycoprotein (mag) |
CA 2183630 CA2183630A1 (en) | 1994-02-21 | 1995-02-17 | Therapeutic use of myelin-associated glycoprotein (mag) |
SE9703032A SE9703032D0 (en) | 1994-02-21 | 1997-08-21 | Therapeutic use of myelin-associated glycoportein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9403250A GB9403250D0 (en) | 1994-02-21 | 1994-02-21 | Therapeutic use of myelin-associated glycoprotein (mag) |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9403250D0 true GB9403250D0 (en) | 1994-04-13 |
Family
ID=10750657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9403250A Pending GB9403250D0 (en) | 1994-02-21 | 1994-02-21 | Therapeutic use of myelin-associated glycoprotein (mag) |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU1703595A (en) |
CA (1) | CA2183630A1 (en) |
GB (1) | GB9403250D0 (en) |
SE (1) | SE9703032D0 (en) |
WO (1) | WO1995022344A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2225691A1 (en) * | 1995-06-27 | 1997-01-16 | Research Foundation Of Cuny, Hunter College | Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
CA2190418A1 (en) * | 1996-11-15 | 1998-05-15 | Zhi-Cheng Xiao | Neuron and neural tumor growth regulatory system, antibodies thereto and uses thereof |
AU3134799A (en) * | 1998-04-16 | 1999-11-08 | Peter Erich Braun | Nevron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration |
US20020072493A1 (en) | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
JP2003532618A (en) * | 1998-05-19 | 2003-11-05 | イエダ リサーチ アンド デベロプメント カンパニイ リミテッド | Cells, nervous system-specific antigens and their uses |
US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
AU2001284865A1 (en) | 2000-08-14 | 2002-02-25 | Joan M. Fallon | Methods for diagnosing and treating dysautonomia and other dysautonomic conditions |
US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
GB0103174D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
TWI323265B (en) * | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
GB0306309D0 (en) * | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
US11016104B2 (en) | 2008-07-01 | 2021-05-25 | Curemark, Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
KR20170005191A (en) | 2009-01-06 | 2017-01-11 | 큐어론 엘엘씨 | Compositions and methods for the treatment or the prevention oral infections by e. coli |
GB2480772B (en) | 2009-01-06 | 2013-10-16 | Curelon Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus |
US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
US8974782B2 (en) | 2011-02-07 | 2015-03-10 | Glaxo Group Limited | Treatment of stroke comprising anti-MAG antibodies |
MX347770B (en) | 2011-04-21 | 2017-05-12 | Curemark Llc | Compounds for the treatment of neuropsychiatric disorders. |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1721092A1 (en) * | 1990-02-26 | 1992-03-23 | Институт Цитологии Ан Ссср | Strain of hydride cultured mammalian cells mus musculus l - a producer of monoclonal antibody to brain myelin glycoproteine, inhibiting activity of natural human killers |
-
1994
- 1994-02-21 GB GB9403250A patent/GB9403250D0/en active Pending
-
1995
- 1995-02-17 WO PCT/CA1995/000089 patent/WO1995022344A1/en active Application Filing
- 1995-02-17 AU AU17035/95A patent/AU1703595A/en not_active Abandoned
- 1995-02-17 CA CA 2183630 patent/CA2183630A1/en not_active Abandoned
-
1997
- 1997-08-21 SE SE9703032A patent/SE9703032D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2183630A1 (en) | 1995-08-24 |
SE9703032D0 (en) | 1997-08-21 |
WO1995022344A1 (en) | 1995-08-24 |
AU1703595A (en) | 1995-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9403250D0 (en) | Therapeutic use of myelin-associated glycoprotein (mag) | |
GB9417956D0 (en) | Therapeutic agents | |
GB9418545D0 (en) | Therapeutic agents | |
GB9415997D0 (en) | Therapeutic agents | |
GB9417310D0 (en) | Therapeutic agents | |
GB9416189D0 (en) | Therapeutic agents | |
GB9420168D0 (en) | Therapeutic agents | |
GB9416162D0 (en) | Therapeutic agents | |
GB9402641D0 (en) | Therapeutic agents | |
GB9410031D0 (en) | Therapeutic agents | |
GB9411955D0 (en) | Therapeutic agents | |
GB9409264D0 (en) | Therapeutic agents | |
GB9415575D0 (en) | Therapeutic agents | |
GB9401879D0 (en) | Therapeutic agents | |
GB9420172D0 (en) | Therapeutic agents | |
GB9403639D0 (en) | Therapeutic agents | |
GB9415553D0 (en) | Therapeutic agents | |
GB9419894D0 (en) | Therapeutic agents | |
GB9415910D0 (en) | Therapeutic agents | |
GB9415805D0 (en) | Therapeutic agents | |
GB9415745D0 (en) | Therapeutic agents | |
GB9415576D0 (en) | Therapeutic agents | |
GB9416161D0 (en) | Therapeutic agents | |
GB9415556D0 (en) | Therapeutic agents | |
GB9416427D0 (en) | Therapeutic agents |